Cite
HARVARD Citation
Barlesi, F. et al. (2018). Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study. Lancet oncology. 19 (11), pp. 1468-1479. [Online].